Literature DB >> 18360687

The potential role of transcription factor aryl hydrocarbon receptor in downregulation of hepatic cytochrome P-450 during sepsis.

Mian Zhou1, Subir R Maitra, Ping Wang.   

Abstract

We recently demonstrated that the hepatic cytochrome P-450 (CYP) isoform 1A2 is downregulated in sepsis, which appears to play an important role in the inflammatory response and liver injury. However, the mechanism responsible for the decreased CYP1A2 remains unknown. Since the transcription factor aryl hydrocarbon receptor (AhR) regulates the expression of CYP1A2 and the disruption of the AhR gene causes liver injuries, we hypothesized that downregulation of AhR plays an important role in the reduced hepatic CYP1A2 during sepsis. Adult male rats were subjected to sepsis by cecal ligation and puncture (CLP). Hepatic tissues were collected at 5, 10, and 20 h after CLP or sham-operation. The gene expression of AhR was assessed by RT-PCR technique. Its protein was determined by Western blot analysis. In addition, subcellular localization of AhR was examined by immunohistochemical staining. The results indicate that hepatic AhR gene expression decreased at 5 h and remained downregulated at 10-20 h after CLP. AhR protein levels were significantly reduced at 10-20 h after CLP. Immunohistochemical examination showed that AhR was mainly located in hepatocyte cytoplasm in sham animals. The translocation of AhR from the cytoplasm to the nucleus was observed in septic animals. The downregulation of hepatic AhR and CYP1A2 observed in septic animals does not appear to be due to the elevated endotoxin levels since administration of polymyxin B (an endotoxin-binding agent) did not affect AhR and CYP1A2 gene expression. However, proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1beta decreased AhR and CYP1A2 expression. As AhR activates the specific gene expression by binding to the target genes, the translocation of AhR to the nucleus in sepsis would suggest that alterations at AhR binding sites may also contribute to the downregulated CYP1A2 expression in sepsis. Since AhR gene expression decreased earlier than the occurrence of depression of CYP1A2 (CYP1A2 decreased at 10-20 h post CLP), the decreased AhR may play an important role in downregulating hepatic CYP1A2 during the progression of sepsis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18360687      PMCID: PMC2694573     

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  37 in total

1.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

2.  Role of cytokines in the lipopolysaccharide-evoked depression of cytochrome P450 in the brain and liver.

Authors:  T E Nicholson; K W Renton
Journal:  Biochem Pharmacol       Date:  2001-12-15       Impact factor: 5.858

3.  Endotoxic shock alters the pharmacokinetics of lidocaine and monoethylglycinexylidide.

Authors:  David S McKindley; Judah Boulet; Karuna Sachdeva; Ping Wang; Clinton Chichester
Journal:  Shock       Date:  2002-03       Impact factor: 3.454

Review 4.  Regulation of cytochrome P450 (CYP) genes by nuclear receptors.

Authors:  P Honkakoski; M Negishi
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

5.  The role of lipopolysaccharide in stimulating adrenomedullin production during polymicrobial sepsis.

Authors:  S Yang; M Zhou; I H Chaudry; P Wang
Journal:  Biochim Biophys Acta       Date:  2001-09-28

6.  Failure of Ah receptor to mediate induction of cytochromes P450 in the CYP1 family in the human hepatoma line SK-Hep-1.

Authors:  E A Roberts; P A Harper; J M Wong; Y Wang; S Yang
Journal:  Arch Biochem Biophys       Date:  2000-12-01       Impact factor: 4.013

7.  Conditional disruption of the aryl hydrocarbon receptor nuclear translocator (Arnt) gene leads to loss of target gene induction by the aryl hydrocarbon receptor and hypoxia-inducible factor 1alpha.

Authors:  S Tomita; C J Sinal; S H Yim; F J Gonzalez
Journal:  Mol Endocrinol       Date:  2000-10

Review 8.  Regulation of cytochrome p450 by inflammatory mediators: why and how?

Authors:  E T Morgan
Journal:  Drug Metab Dispos       Date:  2001-03       Impact factor: 3.922

9.  Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthrene-induced rats.

Authors:  M Spatzenegger; Y Horsmans; R K Verbeeck
Journal:  Pharmacol Toxicol       Date:  2000-02

Review 10.  Induction of drug metabolism: the role of nuclear receptors.

Authors:  Christoph Handschin; Urs A Meyer
Journal:  Pharmacol Rev       Date:  2003-12       Impact factor: 25.468

View more
  8 in total

1.  The role of hepatic cytochrome P-450 in sepsis.

Authors:  Asha Jacob; Mian Zhou; Rongqian Wu; Ping Wang
Journal:  Int J Clin Exp Med       Date:  2009-08-25

2.  Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver.

Authors:  Kathrin Klein; Stefan Winter; Miia Turpeinen; Matthias Schwab; Ulrich M Zanger
Journal:  Front Pharmacol       Date:  2010-11-02       Impact factor: 5.810

3.  Administration of a CXCL12 Analog in Endotoxemia Is Associated with Anti-Inflammatory, Anti-Oxidative and Cytoprotective Effects In Vivo.

Authors:  Semjon Seemann; Amelie Lupp
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

4.  Comprehensive comparison of three different animal models for systemic inflammation.

Authors:  Semjon Seemann; Franziska Zohles; Amelie Lupp
Journal:  J Biomed Sci       Date:  2017-08-24       Impact factor: 8.410

5.  Co-exposure to benzo[a]pyrene and ethanol induces a pathological progression of liver steatosis in vitro and in vivo.

Authors:  Simon Bucher; Arnaud Tête; Normand Podechard; Marie Liamin; Dounia Le Guillou; Martine Chevanne; Cédric Coulouarn; Muhammad Imran; Isabelle Gallais; Morgane Fernier; Quentin Hamdaoui; Marie-Anne Robin; Odile Sergent; Bernard Fromenty; Dominique Lagadic-Gossmann
Journal:  Sci Rep       Date:  2018-04-13       Impact factor: 4.379

6.  Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease.

Authors:  Craig D Fisher; Andrew J Lickteig; Lisa M Augustine; James Ranger-Moore; Jonathan P Jackson; Stephen S Ferguson; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2009-08-03       Impact factor: 3.922

7.  1-Aminobenzotriazole: A Mechanism-Based Cytochrome P450 Inhibitor and Probe of Cytochrome P450 Biology.

Authors:  Paul R Ortiz de Montellano
Journal:  Med Chem (Los Angeles)       Date:  2018-03-31

Review 8.  Current trends in drug metabolism and pharmacokinetics.

Authors:  Yuhua Li; Qiang Meng; Mengbi Yang; Dongyang Liu; Xiangyu Hou; Lan Tang; Xin Wang; Yuanfeng Lyu; Xiaoyan Chen; Kexin Liu; Ai-Ming Yu; Zhong Zuo; Huichang Bi
Journal:  Acta Pharm Sin B       Date:  2019-10-18       Impact factor: 11.413

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.